IPO notice: Penumbra (PEN), a medical device company (2004)

Penumbra company Penumbra Inc (NYSE: PEN) was founded in 2004 and is a Delaware company headquartered in Alameda, California, USA, with 1,000 full-time employees (6/30/2015). It is an interventional therapy company. Engaged in the design, development, manufacturing and sales of innovative medical equipment.

Penumbra Inc Logo

Penumbra (PEN):

Penumbra is a company that focuses on the treatment of neurological diseases. It has recently expanded its business to the field of vascular diseases. In the two challenging medical fields-nervous system diseases and vascular diseases, both have a broad product portfolio and superior medical conditions. , The company’s products are mainly used to treat: ischemic stroke, hemorrhagic stroke, vascular blockage, vascular rupture, thrombosis and embolism.

Penumbra mainly sells its products domestically and globally through its sales force and sales agents.

Penumbra (PEN) memorabilia:

  • In 2007, launched the company’s first product in the United States-neurovascular endoscopy device (the translation may have errors, the original text: neurovascular access);
  • In 2008, Penumbra established a professional direct sales team for neurological disease equipment in the United States and Europe;
  • In 2008, the first inhaled product-510(k)-cleared was launched for the treatment of patients with ischemic stroke. After that, the product was launched for 4 generations;
  • In 2011, Penumbra launched the first neurovascular coil for the treatment of cerebral aneurysms;
  • In 2013, Penumbra launched the first peripheral vascular product (peripheral vascular product);
  • In 2014, Penumbra established a professional direct sales team of peripheral vascular products in the United States and Europe;
  • As of June 30, 2015, the company has 1,000 employees worldwide.

Penumbra (PEN) investment:

Penumbra submitted an IPO prospectus to the SEC on 8/14/2015 , with a planned issue price of US$25.0-28.0 and a raised fund of US$12.36 million. It began trading on the New York Stock Exchange on September 18, 2015, with the stock code: PEN.

Company official website:

American Stock Encyclopedia:

Notify of
Inline Feedbacks
View all Intels

Applied Industrial Technologies (AIT) (1923)

Medical technology company: Acelity Holdings-suspension of listing